Local AI agent brings tumor board expertise to hematological malignancies

Nature Cancer reports a locally deployed AI agent, running on a hospital's own infrastructure, intended to reproduce the work of a multidisciplinary tumour board in haematological malignancies. Local deployment means patient data never leave the institution, which is the main advantage claimed over cloud-based systems. The available report does not state how many cases were assessed, how the system was validated, or how its recommendations compared with tumour board decisions, so this remains a research tool rather than validated clinical decision support.